Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 16.00
-0.15 (-0.93%)
Sep 2, 2026, 4:54 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 422.05 million as of September 2, 2026. Its market cap has increased by 14.89% in one year.
Market Cap
422.05M
Enterprise Value
389.06M
Revenue
11.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.00
ChartMarket Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 422.05M, an increase of 330.81%. That is a compound annual growth rate of 13.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 418.13M | 18.64% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 847.35M |
| Oncopeptides AB | 739.19M |
| FluoGuide | 580.40M |
| Mendus AB | 473.49M |
| Xspray Pharma AB | 470.85M |
| Cantargia AB | 445.01M |
| Intervacc AB | 369.44M |
| Sprint Bioscience AB | 348.20M |